Allarity Therapeutics, Inc. Other Preferred Stock Dividends and Adjustments
Allarity Therapeutics, Inc. (ALLR) reported Other Preferred Stock Dividends and Adjustments of $8.39 million for the 12-month period ending 2023-12-31, per its 10-K filed 2024-03-08.
Discontinued › Expense Statement › Operating Expenses
us-gaap:OtherPreferredStockDividendsAndAdjustments · last filed 2024-03-08
- Allarity Therapeutics, Inc. other preferred stock dividends and adjustments for the quarter ending 2023-12-31 was $0.00, a 100.00% decline year-over-year.
- Allarity Therapeutics, Inc. other preferred stock dividends and adjustments for the quarter ending 2023-09-30 was $1.10M, a 32.87% decline year-over-year.
- Allarity Therapeutics, Inc. other preferred stock dividends and adjustments for the quarter ending 2023-06-30 was $7.29M.
- Allarity Therapeutics, Inc. other preferred stock dividends and adjustments for the quarter ending 2023-03-31 was $0.00, a 100.00% decline year-over-year.
- Allarity Therapeutics, Inc. other preferred stock dividends and adjustments for fiscal 2023 was $8.39M, a 145.31% increase from fiscal 2022.
- Allarity Therapeutics, Inc. other preferred stock dividends and adjustments for fiscal 2022 was $3.42M.
| Period end | Other Preferred Stock Dividends and Adjustments 3 month | Other Preferred Stock Dividends and Adjustments 6 month | Other Preferred Stock Dividends and Adjustments 9 month | Other Preferred Stock Dividends and Adjustments 9 month as first filed | Other Preferred Stock Dividends and Adjustments 12 month |
|---|---|---|---|---|---|
| 2023-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-08 | $1.10M derived: sum of 2 quarters · filed 2024-03-08 | $8.39M derived: sum of 3 quarters · filed 2024-03-08 | $8.39M 10-K · filed 2024-03-08 | |
| 2023-09-30 | $1.10M 10-Q · filed 2023-11-14 | $8.39M derived: sum of 2 quarters · filed 2023-11-14 | $8.39M 10-Q · filed 2023-11-14 | $10.24M derived: sum of 4 quarters · filed 2024-03-08 | |
| 2023-06-30 | $7.29M 10-Q · filed 2023-08-14 | $7.29M 10-Q · filed 2023-08-14 | $9.14M derived: sum of 3 quarters · filed 2024-03-08 | $10.78M derived: sum of 4 quarters · filed 2024-03-08 | |
| 2023-03-31 | $0.00 derived: 10-K 12 month − 3 quarters · filed 2024-03-08 | $1.85M derived: sum of 2 quarters · filed 2024-03-08 | $3.50M derived: sum of 3 quarters · filed 2024-03-08 | $3.50M derived: sum of 4 quarters · filed 2024-03-08 | |
| 2022-12-31 | $1.85M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-13 | $3.50M derived: sum of 2 quarters · filed 2023-03-13 | $3.50M derived: sum of 3 quarters · filed 2023-08-14 | $3.42M 10-K · filed 2023-03-13 | |
| 2022-09-30 | $1.65M 10-Q · filed 2022-11-14 | $1.65M derived: sum of 2 quarters · filed 2023-08-14 | $1.57M 10-Q · filed 2023-11-14 | $3.16M 10-Q · filed 2022-11-14 | |
| 2022-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-14 | $1.57M 10-Q · filed 2023-08-14 | |||
| 2022-03-31 | $1.57M 10-Q · filed 2023-05-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PALATIN TECHNOLOGIES INC (PTN) | United States | $0.017B | -5.36 |
| Lipocine Inc. (LPCN) | United States | $0.017B | -1.79 |
| Pasithea Therapeutics Corp. (KTTA) | United States | $0.017B | -0.81 |
| Biofrontera Inc. (BFRI) | United States | $0.018B | -2.13 |
| Korsana Biosciences, Inc. (CYCN) | United States | $0.016B | |
| Citius Pharmaceuticals, Inc. (CTXR) | United States | $0.016B | -133.06 |
| Rocket One Inc. (RKTO) | United States | $0.019B | |
| Lantern Pharma Inc. (LTRN) | United States | $0.015B | -2.87 |
| Shuttle Pharmaceuticals Holdings, Inc. (SHPH) | United States | $0.019B | -0.31 |
| Anebulo Pharmaceuticals, Inc. (ANEB) | United States | $0.015B |